Congress Small Cap Growth Institutional holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Congress Small Cap Growth Fund Institutional Class CSMCX
- NAV / 1-Day Return $54.32 / +0.11 %
- Fund Size $2.0B
- Adjusted Expense Ratio 1.010%
- Net Expense Ratio 1.000%
- Fee Level: Distribution Above Average
- Share Class Type Institutional
- Morningstar Category Small Growth
- Equity Style Box (Funds) Small Growth
- Minimum Initial Investment $100,000
- Investment Status Open
- TTM Yield 0.00%
- Turnover Ratio 34%
Morningstar’s Analysis CSMCX
Will CSMCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 34.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Ligand Pharmaceuticals Inc | 4.11 | 82M | Healthcare |
Repligen Corp | 3.71 | 74M | Healthcare |
TG Therapeutics Inc | 3.63 | 73M | Healthcare |
Moog Inc Class A | 3.63 | 72M | Industrials |
Imax Corp | 3.57 | 71M | Communication Services |
InterDigital Inc | 3.27 | 65M | Technology |
UFP Technologies Inc | 3.20 | 64M | Healthcare |
CommVault Systems Inc | 3.16 | 63M | Technology |
JFrog Ltd Ordinary Shares | 3.14 | 63M | Technology |
Sensient Technologies Corp | 3.08 | 61M | Basic Materials |